GERN
Geron Corp
Price:  
1.27 
USD
Volume:  
6,386,384.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-231.4%
Upside

As of 2025-09-18, the EV/EBITDA ratio of Geron Corp (GERN) is -11.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 851.54 mil USD. GERN's TTM EBITDA according to its financial statements is -76.54 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.4x - 13.6x 11.0x
Forward P/E multiples 12.3x - 19.2x 15.8x
Fair Price (1.54) - (1.70) (1.67)
Upside -221.3% - -233.6% -231.4%
1.27 USD
Stock Price
(1.67) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-15 -11.12
2025-09-12 -11.12
2025-09-11 -11.54
2025-09-10 -11.29
2025-09-09 -11.88
2025-09-08 -11.96
2025-09-05 -12.21
2025-09-04 -12.04
2025-09-03 -12.21
2025-09-02 -12.79
2025-08-29 -12.21
2025-08-28 -12.46
2025-08-27 -12.29
2025-08-26 -12.71
2025-08-25 -12.38
2025-08-22 -12.71
2025-08-21 -12.46
2025-08-20 -12.13
2025-08-19 -12.46
2025-08-18 -12.54
2025-08-15 -12.63
2025-08-14 -12.63
2025-08-13 -12.46
2025-08-12 -11.79
2025-08-11 -11.88
2025-08-08 -11.21
2025-08-07 -11.37
2025-08-06 -12.13
2025-08-05 -10.54
2025-08-04 -10.62
2025-08-01 -10.29
2025-07-31 -10.12
2025-07-30 -9.71
2025-07-29 -10.00
2025-07-28 -10.12
2025-07-25 -11.04
2025-07-24 -11.21
2025-07-23 -11.62
2025-07-22 -11.21
2025-07-21 -10.79
2025-07-18 -10.87
2025-07-17 -11.29
2025-07-16 -11.12
2025-07-15 -11.04
2025-07-14 -11.71
2025-07-11 -11.54
2025-07-10 -12.04
2025-07-09 -12.54
2025-07-08 -12.13
2025-07-07 -11.96